Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin(r)) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)
CT-P16;Avastin;Bevacizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin(r)) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC) ### Output: CT-P16;Avastin;Bevacizumab